Caroline Tillett - Feb 13, 2024 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Scientific Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Stock symbol
KVUE
Transactions as of
Feb 13, 2024
Transactions value $
-$19,882
Form type
4
Date filed
2/15/2024, 05:27 PM
Previous filing
Feb 12, 2024
Next filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVUE Common Stock Options Exercise $0 +3K +15.97% $0.00 21.8K Feb 13, 2024 Direct F1
transaction KVUE Common Stock Tax liability -$19.9K -1.03K -4.72% $19.34 20.8K Feb 13, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Options Exercise $0 -3K -33.36% $0.00 5.99K Feb 13, 2024 Common Stock 3K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.